|
|
|
|
| LEADER |
01626nmm a2200409 u 4500 |
| 001 |
EB002176981 |
| 003 |
EBX01000000000000001314515 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
231006 ||| eng |
| 100 |
1 |
|
|a Deen, G. Roshan
|
| 245 |
0 |
0 |
|a Liposomes as a drug delivery system
|h Elektronische Ressource
|c Renad AlAnsari, Bushra Hasan, Roshan Deen
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2023, 2023
|
| 300 |
|
|
|a 1 streaming video file (17 min.)
|b color, sound
|
| 505 |
0 |
|
|a Contents: Types of liposomes -- Advantages of liposomes for drug delivery -- Doxil -- DaunoXome -- Sterically-stabilized liposomes -- Ligand-targeted liposomes -- Polyethylene glycol (PEG) -- Challenges with liposomes
|
| 653 |
|
|
|a Liposomes
|
| 653 |
|
|
|a Nanomedicine
|
| 653 |
|
|
|a Pharmaceutical biotechnology
|
| 653 |
|
|
|a Doxorubicin
|
| 653 |
|
|
|a Lipsomes / Biotechnology
|
| 653 |
|
|
|a liposomal doxorubicin
|
| 653 |
|
|
|a Daunorubicin
|
| 653 |
|
|
|a Drug Delivery Systems / methods
|
| 653 |
|
|
|a Drug targeting
|
| 653 |
|
|
|a Drug delivery systems
|
| 653 |
|
|
|a Nanotechnology
|
| 653 |
|
|
|a Polyethylene Glycols
|
| 653 |
|
|
|a Drug carriers (Pharmacy)
|
| 700 |
1 |
|
|a AlAnsari, Renad
|
| 700 |
1 |
|
|a Hasan, Bushra
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Drug delivery
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/1038
|3 Series
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/5418
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|